Levothyroxine Dosage and the Increased Risk of Second Primary Malignancy in Thyroid Cancer Survivors Young…
Levothyroxine Dosage and the Increased Risk of Second Primary Malignancy in Thyroid Cancer Survivors Young…
We are thrilled to announce that Theodora Pappa, MD, PhD, has been awarded the 2023…
Join us this fall for the premier professional event in thyroidology and immerse yourself in…
Registration Open! Register today for the 2024 ATA Annual Meeting on October 30 – November…
From Clinical Thyroidology® for the Public: The goal of thyroid hormone therapy in thyroid cancer…
VideoEndocrinology™ We invite you to view these selected videos from the ATA Centennial Interview Series…
From Clinical Thyroidology® for the Public: Elevated thyroid antibodies in the mother during pregnancy have…
From Clinical Thyroidology® for the Public: The goal of treating hypothyroidism is achieving a TSH…
Latest Impact Factor: Latest Impact Factor: : 6.506 The Official Journal of: American Thyroid Association®…
Advanced Radioactive Iodine Refractory-Differentiated Thyroid Cancer: Current Management Perspectives Sarimar Agosto Salgado, MD Moffitt Cancer…